{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T05:19:24Z","timestamp":1735190364246,"version":"3.32.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.prp.2024.155439","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T17:18:07Z","timestamp":1719854287000},"page":"155439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Additional confirmation of successful cell suspension fractionation of metastatic axillary node tissue"],"prefix":"10.1016","volume":"260","author":[{"given":"Vesna","family":"Ivanovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sne\u017eana","family":"Tepav\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasta","family":"Dedovi\u0107-Tani\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zorka","family":"Milovanovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bratislav","family":"Stojiljkovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tijana","family":"Vasiljevi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"Mandu\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2024.155439_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2024.155439_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/DDDT.S336643","article-title":"The role of progesterone receptors in breast cancer","volume":"16","author":"Li","year":"2022","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.prp.2024.155439_bib3","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","article-title":"HER2-positive breast cancer","volume":"389","author":"Loibl","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2024.155439_bib4","first-page":"1","article-title":"A review of prognostic and predictive biomarkers in breast cancer","volume":"23","author":"Tarighati","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"19","key":"10.1016\/j.prp.2024.155439_bib5","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.3390\/cancers13194972","article-title":"Type 1 nuclear receptor activity in breast cancer: translating preclinical insights to the clinic","volume":"13","author":"Kumar","year":"2021","journal-title":"Cancers"},{"issue":"19","key":"10.1016\/j.prp.2024.155439_bib6","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.3390\/cancers13194779","article-title":"Steroid receptors in breast cancer: understanding of molecular function as a basis for effective therapy development","volume":"13","author":"Kowalczyk","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2024.155439_bib7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ccr.2014.02.025","article-title":"ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics","volume":"25","author":"Arteaga","year":"2014","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.prp.2024.155439_bib8","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.3390\/ijms24076834","article-title":"A basic review on estrogen receptor signaling pathways in breast cancer","volume":"24","author":"Clusan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155439_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3121\/cmr.2008.825","article-title":"Breast cancer subtypes based on ER\/PR and Her2 expression: comparison of clinicopathologic features and survival","volume":"7","author":"Onitilo","year":"2009","journal-title":"Clin. Med. Res."},{"key":"10.1016\/j.prp.2024.155439_bib10","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1200\/JCO.2015.61.1459","article-title":"Use of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: american society of clinical oncology clinical practice guideline","volume":"33","author":"Van Poznak","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155439_bib11","first-page":"117","article-title":"Comparison of estrogen and progesterone receptor status in tumor mass and axillary lymph node metastasis in patients with carcinoma breast","volume":"10","author":"Singh","year":"2020","journal-title":"Int. J. Appl. Basic Med. Res."},{"key":"10.1016\/j.prp.2024.155439_bib12","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jnci\/djx273","article-title":"Receptor conversion in distant breast cancer metastases: a systematic review and meta-analysis","volume":"110","author":"Schrijver","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2024.155439_bib13","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1002\/cncr.27518","article-title":"Prognostic value of estrogen receptor alpha and progesterone receptor conversion in distant breast cancer metastases","volume":"118","author":"Hoefnagel","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2024.155439_bib14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10549-011-1632-x","article-title":"HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis","volume":"129","author":"Houssami","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2024.155439_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.29252\/ibj.24.3.183","article-title":"Novel biomarkers aim at detecting metastatic sentinel lymph nodes in breast cancer","volume":"24","author":"Bakaeean","year":"2020","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.prp.2024.155439_bib16","unstructured":"Advantages and Disadvantages of Immunohistochemistry. Available at: https:\/\/dermnetnz.org\/topics\/immunohistochemistry-stains Accessed 29\/11\/2023."},{"key":"10.1016\/j.prp.2024.155439_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12575-022-00167-x","article-title":"Establishment and fractionation of metastatic axillary lymph node cell suspension for determination of protein expression levels of nuclear cFOS and cytosolic TGFbeta1 from breast cancer patients.","volume":"24","author":"Ivanovic","year":"2022","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.prp.2024.155439_bib18","unstructured":"American Joint Committee on Cancer, AJCC cancer staging manual, 8th edn. Springer, Chicago, 2016."},{"key":"10.1016\/j.prp.2024.155439_bib19","unstructured":"DAKO IHC Guidebook. Innunohistochemical Staining Methods. https:\/\/www.akoyabio.com\/wp-content\/uploads\/2020\/04\/08002_ihc_staining_methods.pdf."},{"key":"10.1016\/j.prp.2024.155439_bib20","unstructured":"Determination of Total Protein by the Lowry Method Using the BioTek Instruments\u2019 ELx808 Microplate Reader https:\/\/www.biotek.com\/resources\/docs\/ELx808_Determining_Total_Protein_Lowry_Method.pdf."},{"key":"10.1016\/j.prp.2024.155439_bib21","first-page":"1","article-title":"Cholecalciferol ameliorates insulin signalling and insulin regulation of enzymes involved in glucose metabolism in the rat heart","author":"Ivkovic","year":"2021","journal-title":"Arch. Physiol. Biochem"},{"key":"10.1016\/j.prp.2024.155439_bib22","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1002\/elps.200500785","article-title":"Beta-actin is not a reliable loading control in Western blot analysis","volume":"27","author":"Dittmer","year":"2006","journal-title":"Electrophoresis"},{"key":"10.1016\/j.prp.2024.155439_bib23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(98)11104-2","article-title":"Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International breast cancer study group","volume":"354","author":"Cote","year":"1999","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.prp.2024.155439_bib24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1445-2197.2002.02518.x","article-title":"New technique to assess the axilla for breast cancer metastases using cell separation technology","volume":"72","author":"Edwards","year":"2002","journal-title":"ANZ J. Surg."},{"key":"10.1016\/j.prp.2024.155439_bib25","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1200\/JCO.2005.05.0666","article-title":"Estrogen receptor testing of breast cancer in current clinical practice: what's the question?","volume":"24","author":"Schnitt","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155439_bib26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-018-4948-y","article-title":"Only estrogen receptor \"positive\" is not enough to predict the prognosis of breast cancer","volume":"172","author":"Ryu","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2024.155439_bib27","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1200\/JCO.2006.07.7537","article-title":"Bimodal population or pathologist artifact?","volume":"25","author":"Rimm","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155439_bib28","first-page":"867","article-title":"The value of estrogen and progesterone receptor determinations in advanced breast cancer","volume":"68","author":"Bezwoda","year":"1991","journal-title":"Estrogen Recept. Lev. But Not. Progesterone Recept. Lev. Correl. Response Tamoxifen. Cancer"},{"key":"10.1016\/j.prp.2024.155439_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.canlet.2012.02.022","article-title":"Different associations of estrogen receptor beta isoforms, ERbeta1 and ERbeta2, expression levels with tumor size and survival in early- and late-onset breast cancer","volume":"321","author":"Mandusic","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2024.155439_bib30","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00432-007-0209-x","article-title":"Expression of estrogen receptor beta wt isoform (ERbeta1) and ERbetaDelta5 splice variant mRNAs in sporadic breast cancer","volume":"133","author":"Mandusic","year":"2007","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155439_bib31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF03401288","article-title":"The estrogen receptor: two or more molecules, multiple variants, diverse localizations, signaling and functions. Are we undergoing a paradigm-shift as regards their significance in breast cancer?","volume":"12","author":"Kampa","year":"2013","journal-title":"Horm."},{"key":"10.1016\/j.prp.2024.155439_bib32","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1194\/jlr.M085191","article-title":"Sphingosine kinase 1 activation by estrogen receptor alpha36 contributes to tamoxifen resistance in breast cancer","volume":"59","author":"Maczis","year":"2018","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.prp.2024.155439_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195877","article-title":"One-Step Nucleic Acid Amplification (OSNA): a fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer","volume":"13","author":"Fanfani","year":"2018","journal-title":"PLoS ONE"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824003509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824003509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T19:23:14Z","timestamp":1735154594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824003509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":33,"alternative-id":["S0344033824003509"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155439","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Additional confirmation of successful cell suspension fractionation of metastatic axillary node tissue","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155439"}}